First Citizens Bank & Trust’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

First Citizens Bank & Trust’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$11.1M	Sell	170,502 -25,199	-13%	-$1.74M	0.16%	86
2026 Q2	$13M	Buy	195,701 +8,304	+4%	+$486K	0.19%	80
2026 Q1	$10.1M	Buy	187,397 +1,393	+0.7%	+$77.6K	0.21%	79
2025 Q4	$10.4M	Buy	186,004 +4,575	+3%	+$237K	0.22%	84
2025 Q3	$8.7M	Buy	181,429 +5,038	+3%	+$225K	0.19%	94
2025 Q2	$7.16M	Buy	176,391 +47,885	+37%	+$1.92M	0.13%	95
2025 Q1	$5.63M	Buy	128,506 +810	+0.6%	+$35.7K	0.14%	99
2024 Q4	$5.49M	Buy	127,696 +55,643	+77%	+$2.53M	0.1%	101
2024 Q3	$3.2M	Buy	72,053 +6,227	+9%	+$267K	0.07%	154
2024 Q2	$2.62M	Buy	65,826 +1,709	+3%	+$69.2K	0.05%	165
2024 Q1	$2.77M	Buy	64,117 +12,325	+24%	+$531K	0.05%	160
2023 Q4	$2.16M	Sell	51,792 -6,647	-11%	-$252K	0.04%	162
2023 Q3	$2.32M	Buy	58,439 +748	+1%	+$31.7K	0.05%	142
2023 Q2	$2.36M	Buy	57,691 +13,588	+31%	+$561K	0.04%	146
2023 Q1	$1.81M	Buy	44,103 +8,173	+23%	+$343K	0.04%	153
2022 Q4	$1.47M	Buy	35,930 +662	+2%	+$27.6K	0.04%	156
2022 Q3	$1.42M	Sell	35,268 -11,402	-24%	-$488K	0.05%	156
2022 Q2	$1.96M	Sell	46,670 -1,660	-3%	-$69.6K	0.07%	124
2022 Q1	$2.19M	Buy	48,330 +964	+2%	+$42.4K	0.09%	122
2021 Q4	$2.19M	Buy	47,366 +1,628	+4%	+$77.1K	0.09%	120
2021 Q3	$2.17M	Sell	45,738 -203	-0.4%	-$10.1K	0.1%	114
2021 Q2	$2.38M	Sell	45,941 -1,500	-3%	-$75.3K	0.11%	108
2021 Q1	$2.39M	Sell	47,441 -1,362	-3%	-$72.6K	0.11%	119
2020 Q4	$2.54M	Sell	48,803 -862	-2%	-$41.2K	0.13%	107
2020 Q3	$2.16M	Sell	49,665 -1,620	-3%	-$71K	0.15%	119
2020 Q2	$2.2M	Buy	51,285 +5,836	+13%	+$241K	0.18%	111
2020 Q1	$1.64M	Buy	45,449 +4,355	+11%	+$186K	0.2%	112
2019 Q4	$1.88M	Buy	+41,094	New	+$1.63M	0.18%	115

Other funds holding XPH

GDP

Great Diamond Partners Portland, Maine $596M AUM 19.61% 1-Year Est. Return

AWM

Avior Wealth Management Omaha, Nebraska $3.79B AUM 15.36% 1-Year Est. Return

CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return

FFA

Fragasso Financial Advisors Sewickley, Pennsylvania $1.99B AUM 16.69% 1-Year Est. Return

IFG

Independent Financial Group San Diego, California $5.51B AUM 33.52% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

KFS

Kaizen Financial Strategies Campbell, California $254M AUM 28.38% 1-Year Est. Return

CIA

Cape Investment Advisory Mcdonough, Georgia $388M AUM 17.15% 1-Year Est. Return

Mather Group Chicago, Illinois $11.8B AUM 12.84% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

First Citizens Bank & Trust's XPH Position: Q3 2026 in Review

First Citizens Bank & Trust reduced its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 13% in Q3 2026, selling an estimated $1.74M and leaving 170,502 shares worth $11.1M. The position accounts for 0.16% of the portfolio, ranked #86.

First Citizens Bank & Trust first reported a position in XPH in Q4 2019 and has held it in 28 quarters since. The position peaked at $13M in Q2 2026. 11 funds tracked by Wall St. Rank hold XPH as of Q3 2026.

First Citizens Bank & Trust held 170,502 shares of State Street SPDR S&P Pharmaceuticals ETF worth $11.1M as of Q3 2026.
First Citizens Bank & Trust sold 25,199 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2026, an estimated $1.74M.
State Street SPDR S&P Pharmaceuticals ETF made up 0.16% of First Citizens Bank & Trust's portfolio in Q3 2026, its #86 holding.
First Citizens Bank & Trust first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2019 and has held it in 28 quarters since.
First Citizens Bank & Trust's State Street SPDR S&P Pharmaceuticals ETF position peaked at $13M in Q2 2026.
11 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2026.

Based on First Citizens Bank & Trust's 13F filing for Q3 2026, filed 14 Oct 2026.